Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 12,500 shares at $198.47 ($2.5M) on 2021-11-23, disclosed to the SEC on 2021-11-24.
Open-market sale of $2.5M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $196.43 | 800 | $157K | 6.3% |
| 2 | $197.44 | 1,400 | $276K | 11.1% |
| 3 | $198.47 | 1,271 | $252K | 10.1% |
| 4 | $198.47 | 1,271 | $252K | 10.1% |
| 5 | $199.51 | 1,387 | $277K | 11.1% |
| 6 | $199.51 | 1,387 |
| $277K |
| 11.1% |
| 7 | $200.55 | 1,600 | $321K | 12.9% |
| 8 | $201.48 | 722 | $145K | 5.8% |
| 9 | $201.48 | 722 | $145K | 5.8% |
| 10 | $202.65 | 870 | $176K | 7.1% |
| 11 | $202.65 | 870 | $176K | 7.1% |
| 12 | $203.62 | 200 | $41K | 1.6% |
| Total | $199.73 avg | 12,500 | $2.5M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |